Poly(d,l-lactic acid)-glycerol-based nanoparticles for curcumin delivery

International Journal of Pharmaceutics

Volumn 488, Issue 1-2, 2015, Pages 70-77

  Yoon, In Soo ^a   Park, Ju Hwan ^b   Kang, Hyo Jin ^c   Choe, Ji Hyeong ^c   Goh, Min Su ^c   Kim, Dae Duk ^b   Cho, Hyun Jong ^c  

^a Mokpo National University   (South Korea)

^b Seoul National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Cancer; Curcumin; Nanoparticle; PDLLA glycerol; Pharmacokinetics

Indexed keywords

CURCUMIN; GLYCEROL; NANOPARTICLE; POLYGLACTIN; ANTINEOPLASTIC AGENT; LACTIC ACID; POLYLACTIC ACID; POLYMER;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MEAN RESIDENCE TIME; NONHUMAN; PARTICLE SIZE; PH; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; VOLUME OF DISTRIBUTION AT STEADY-STATE; ANIMAL; CHEMISTRY; DRUG RELEASE; MEDICINAL CHEMISTRY; PROCEDURES; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; DRUG LIBERATION; GLYCEROL; LACTIC ACID; MALE; NANOPARTICLES; PARTICLE SIZE; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84928492219     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.046     Document Type: Article

References (49)

1. D.K. Agrawal, and P.K. Mishra Curcumin and its analogues: potential anticancer agents Med. Res. Rev. 30 2010 818 860
2. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
3. I. Arvanitoyannis, A. Nakayama, N. Kawasaki, and N. Yamamoto Novel star-shaped polylactide with glycerol using stannous octoate or tetraphenyl tin as catalyst: 1. Synthesis, characterization and study of their biodegradability Polymer 36 1995 2947 2956
4. S. Barui, S. Saha, G. Mondal, S. Haseena, and A. Chaudhuri Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature Biomaterials 35 2014 1643 1656
5. L. Basile, R. Pignatello, and C. Passirani Active targeting strategies for anticancer drug nanocarriers Curr. Drug Deliv. 9 2012 255 268
6. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Deliv. Rev 66 2014 2 25
7. H. Chen, S. Kim, W. He, H. Wang, P.S. Low, K. Park, and J.X. Cheng Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging Langmuir 24 2008 5213 5217
8. A.L. Cheng, C.H. Hsu, J.K. Lin, M.M. Hsu, Y.F. Ho, T.S. Shen, J.Y. Ko, J.T. Lin, B.R. Lin, W. Ming-Shiang, H.S. Yu, S.H. Jee, G.S. Chen, T.M. Chen, C.A. Chen, M.K. Lai, Y.S. Pu, M.H. Pan, Y.J. Wang, C.C. Tsai, and C.Y. Hsieh Phase I clinical trial of curcumin a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res. 21 2001 2895 2900
9. H.J. Cho, H.Y. Yoon, H. Koo, S.H. Ko, J.S. Shim, J.H. Lee, K. Kim, I.C. Kwon, and D.D. Kim Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
10. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
11. H.J. Cho, J.W. Park, I.S. Yoon, and D.D. Kim Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake Int. J. Nanomed. 9 2014 495 504
12. Y. Dong, K.T. Love, J.R. Dorkin, S. Sirirungruang, Y. Zhang, D. Chen, R.L. Bogorad, H. Yin, Y. Chen, A.J. Vegas, C.A. Alabi, G. Sahay, K.T. Olejnik, W. Wang, A. Schroeder, A.K. Lytton-Jean, D.J. Siegwart, A. Akinc, C. Barnes, S.A. Barros, M. Carioto, K. Fitzgerald, J. Hettinger, V. Kumar, T.I. Novobrantseva, J. Qin, W. Querbes, V. Kotelianski, R. Langer, and D.G. Anderson Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates Proc. Natl. Acad. Sci. U. S. A. 111 2014 3955 3960
13. P. Dulbecco, and V. Savarino Therapeutic potential of curcumin in digestive diseases World J. Gastroenterol. 19 2013 9256 9270
14. J. Fang, H. Nakamura, and H. Maeda The EPR effect unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
15. R. Feng, Z. Song, and G. Zhai Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles Int. J. Nanomed. 7 2012 4089 4098
16. S. Fujisawa, T. Atsumi, M. Ishihara, and Y. Kadoma Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds Anticancer Res. 24 2004 563 570
17. A. Gulotta, A.H. Saberi, M.C. Nicoli, and D.J. McClements Nanoemulsion-based delivery systems for polyunsaturated (ω-3) oils: formation using a spontaneous emulsification method J. Agric. Food Chem. 62 2014 1720 1725
18. M.K. John, H. Xie, E.C. Bell, and D. Liang Development and pharmacokinetic evaluation of a curcumin co-solvent formulation Anticancer Res. 33 2013 4285 4291
19. V. Joshi, G.A. Ahmed, S. Suresh, and R. Kowti A comparative study: solution stability and dissolution behavior of solid dispersion curcumin Indian J. Novel Drug Deliv. 2 2012 88 95
20. V. Kakkar, S. Singh, D. Singla, S. Sahwney, A.S. Chauhan, G. Singh, and I.P. Kaur Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878 2010 3427 3431
21. B.T. Kurien, A. Singh, H. Matsumoto, and R.H. Scofield Improving the solubility and pharmacological efficacy of curcumin by heat treatment Assay Drug Dev. Technol. 5 2007 567 576
22. J.Y. Lee, J.S. Kim, H.J. Cho, and D.D. Kim Poly(styrene)-b-poly(dl-lactide) copolymer-based nanoparticles for anticancer drug delivery Int. J. Nanomed. 9 2014 2803 2813
23. Z. Liu, Y. Jiao, T. Wang, Y. Zhang, and W. Xue Interactions between solubilized polymer molecules and blood components J. Control Release 160 2012 14 24
24. Z.D. Lv, X.P. Liu, W.J. Zhao, Q. Dong, F.N. Li, H.B. Wang, and B. Kong Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo Int. J. Clin. Exp. Pathol. 7 2014 2818 2824
25. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 65 2000 271 284
26. L. Mazzarino, I. Otsuka, S. Halila, S. Bubniak Ldos, S. Mazzucco, M.C. Santos-Silva, E. Lemos-Senna, and R. Borsali Xyloglucan-block-poly(ε-caprolactone) copolymer nanoparticles coated with chitosan as biocompatible mucoadhesive drug delivery system Macromol. Biosci. 14 2014 709 719
27. B. Meng, J. Li, and H. Cao Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications Curr. Pharm. Des. 19 2013 2101 2113
28. O. Naksuriya, S. Okonogi, R.M. Schiffelers, and W.E. Hennink Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment Biomaterials 35 2014 3365 3383
29. A.L. Palange, D. Di Mascolo, C. Carallo, A. Gnasso, and P. Decuzzi Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells Nanomedicine 10 2014 991 1002
30. J.H. Park, H.J. Cho, H.Y. Yoon, I.S. Yoon, S.H. Ko, J.S. Shim, J.H. Cho, J.H. Park, K. Kim, I.C. Kwon, and D.D. Kim Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery J. Controlled Release 174 2014 98 108
31. J.H. Park, J.Y. Lee, U. Termsarasab, I.S. Yoon, S.H. Ko, J.S. Shim, H.J. Cho, and D.D. Kim Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery Int. J. Pharm. 473 2014 426 433
32. K.I. Priyadarsini Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells J. Photochem. Photobiol. C Photochem. Rev. 10 2009 81 95
33. K. Rausch, A. Reuter, K. Fischer, and M. Schmidt Evaluation of nanoparticle aggregation in human blood serum Biomacromolecules 11 2010 2836 2839
34. C.A. Reddy, V. Somepalli, T. Golakoti, A.K. Kanugula, S. Karnewar, K. Rajendiran, N. Vasagiri, S. Prabhakar, P. Kuppusamy, S. Kotamraju, and V.K. Kutala Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin PLoS One 9 2014 e89351
35. R. Schnettler, H.J. Pfefferle, O. Kilian, C. Heiss, J. Kreuter, D. Lommel, T. Pavlidis, J.P. Stahl, C. Meyer, S. Wenisch, and V. Alt Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants J. Controlled Release 106 2005 154 161
36. R.A. Sharma, W.P. Steward, and A.J. Gescher Pharmacokinetics and pharmacodynamics of curcumin Adv. Exp. Med. Biol. 595 2007 453 470
37. A. Shehzad, G. Rehman, and Y.S. Lee Curcumin in inflammatory diseases Biofactors 39 2013 69 77
38. A. Shehzad, F. Wahid, and Y.S. Lee Curcumin in cancer chemoprevention: molecular targets pharmacokinetics, bioavailability, and clinical trials Arch. Pharm. (Weinheim) 343 2010 489 499
39. R.A. Shenoi, B.F. Lai, M. Imran ul-haq, D.E. Brooks, and J.N. Kizhakkedathu Biodegradable polyglycerols with randomly distributed ketal groups as multi-functional drug delivery systems Biomaterials 34 2013 6068 6081
40. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med. 64 1998 353 356
41. S. Singh, and S.S. Ray Polylactide based nanostructured biomaterials and their applications J. Nanosci. Nanotechnol. 7 2007 2596 2615
42. Z. Song, W. Zhu, N. Liu, F. Yang, and R. Feng Linolenic acid-modified PEG-PCL micelles for curcumin delivery Int. J. Pharm. 471 2014 312 321
43. Z.J. Sun, B. Sun, R.B. Tao, X. Xie, X.L. Lu, and D.L. Dong A poly(glycerol-sebacate-curcumin) polymer with potential use for brain gliomas J. Biomed. Mater. Res. A 101 2013 253 260
44. H.H. Tønnesen, M. Másson, and T. Loftsson Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int. J. Pharm. 244 2002 127 135
45. B.L. Wang, Y.M. Shen, Q.W. Zhang, Y.L. Li, M. Luo, Z. Liu, Y. Li, Z.Y. Qian, X. Gao, and H.S. Shi Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer Int. J. Nanomed. 8 2013 3521 3531
46. M.M. Yallapu, S. Khan, D.M. Maher, M.C. Ebeling, V. Sundram, N. Chauhan, A. Ganju, S. Balakrishna, B.K. Gupta, N. Zafar, M. Jaggi, and S.C. Chauhan Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer Biomaterials 35 2014 8635 8648
47. K.Y. Yang, L.C. Lin, T.Y. Tseng, S.C. Wang, and T.H. Tsai Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 853 2007 183 189
48. Y. Yu, C.K. Chen, W.C. Law, E. Weinheimer, S. Sengupta, P.N. Prasad, and C. Cheng Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery Biomacromolecules 15 2014 524 532
49. A.L. Zampieri, F.S. Ferreira, E.C. Resende, M.P. Gaeti, D.G. Diniz, S.F. Taveira, and E.M. Lima Biodegradable polymeric nanocapsules based on poly(dl-lactide) for genistein topical delivery: obtention, characterization and skin permeation studies J. Biomed. Nanotechnol. 9 2013 527 534